PharmaCyte Biotech Inc (OTCMKTS:PMCBD – Get Free Report) rose 0% during mid-day trading on Friday . The company traded as high as $0.6108 and last traded at $0.5901. Approximately 30,044 shares traded hands during trading, an increase of 240% from the average session volume of 8,831 shares. The stock had previously closed at $0.59.
PharmaCyte Biotech Stock Up 0.0%
The company’s 50 day simple moving average is $0.70 and its 200 day simple moving average is $0.73.
PharmaCyte Biotech Company Profile
PharmaCyte Biotech is a clinical‐stage biotechnology company focused on the development and commercialization of targeted cellular therapies for cancer and diabetes. The company’s core technology, Cell-in-a-Box, encapsulates live, genetically modified cells within a proprietary cellulose‐based polymer matrix. This platform is designed to deliver therapeutic agents directly at tumor sites or within the pancreas, with the goal of maximizing efficacy while minimizing systemic side effects.
In its lead oncology program, PharmaCyte is conducting clinical trials for advanced pancreatic cancer, combining Cell-in-a-Box–encased cells with the prodrug ifosfamide.
Further Reading
- Five stocks we like better than PharmaCyte Biotech
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for PharmaCyte Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmaCyte Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
